Open | 0.33 |
Previous Close | 0.2801 |
Day Range | 0.33 - 0.54 |
52-Week Range | 0.25 - 8.44 |
All-Time High | 462.60 |
Avg. Volume (50-day) | 3,394.74 |
EPS (TTM) | -28.1869 |
Next Earnings Date | 2025-04-07 (AMC) |
Last Earnings Date | 2024-11-07 |
Forward Annual Dividend (Yield) | - |
Trailing Annual Dividend (Yield) | - |
Options | No |
P/E Ratio | -0.0100 |
PEG Ratio | - |
Price to Book | -0.02 |
Price to Cash Flow | - |
Price to Free Cash Flow | - |
Total Sales (TTM) | 13.53 M |
Revenue per Share (TTM) | 7.63 |
Shares Outstanding | 1.776 M |
Share Float (%) | 1.34 M |
% Held by Institutions | 0.67 |
Dividends Per Share (TTM) | - |
Ex-Dividend Date | - |
+/- EMA(20) | 0.33 (+30.30%) |
+/- SMA(50) | 0.35 (+22.86%) |
+/- SMA(200) | 1.98 (-78.28%) |
5-Day Perf. | +48.28% |
1-Month Perf. | +22.86% |
3-Month Perf. | +7.5% |
6-Month Perf. | -83.14% |
YTD Perf. | +7.5% |
1-Year Perf. | -94.82% |
RSI(14) | 59.88 |
ATR(14) | 0.07 |
ADX(14) | 18.51 |
Beta (5Y) | - |
Telesis Bio, Inc. engages in the provision of automated multi-omic and synthetic biology solutions. The firm also focuses on providing applications to enable researchers to rapidly, accurately, and reproducibly build or write synthetic DNA and mRNA and short oligonucleotides such as CRISPR guides that are ready to use in many downstream synthetic biology enabled markets. The company was founded by Daniel G. Gibson and J. Craig Venter on March 24, 2011 and is headquartered in San Diego, CA.
TBIO has triggered the following predefined scans:
No Recent Scan Appearances |
As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.
As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.